tiprankstipranks
Sonoma Pharmaceuticals (SNOA)
NASDAQ:SNOA
US Market

Sonoma Pharmaceuticals (SNOA) Technical Analysis

Compare
283 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Sonoma Pharmaceuticals’s (SNOA) Moving Averages Convergence Divergence (MACD) indicator is -0.06, suggesting Sonoma Pharmaceuticals is a Buy.
Sonoma Pharmaceuticals’s (SNOA) 20-Day exponential moving average is 2.57, while Sonoma Pharmaceuticals’s (SNOA) share price is $2.4, making it a Sell.
Sonoma Pharmaceuticals’s (SNOA) 50-Day exponential moving average is 2.67, while Sonoma Pharmaceuticals’s (SNOA) share price is $2.4, making it a Sell.

Sonoma Pharmaceuticals (SNOA) Pivot Points

Feb 22, 2025, 11:56 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.15
2.23
2.32
2.40
2.49
2.57
2.66
Fibonacci
2.23
2.29
2.33
2.40
2.46
2.50
2.57
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Sonoma Pharmaceuticals (SNOA) Moving Averages

Feb 22, 2025, 11:56 PM
Period
Simple
Exponential
MA5
2.46Sell
2.46Sell
MA10
2.53Sell
2.51Sell
MA20
2.61Sell
2.57Sell
MA50
2.65Sell
2.67Sell
MA100
2.75Sell
2.89Sell
MA200
3.70Sell
3.35Sell
Sonoma Pharmaceuticals’s (SNOA) 10-Day exponential moving average is 2.51, while Sonoma Pharmaceuticals’s (SNOA) share price is $2.4, making it a Sell.
Sonoma Pharmaceuticals’s (SNOA) 100-Day exponential moving average is 2.89, while Sonoma Pharmaceuticals’s (SNOA) share price is $2.4, making it a Sell.
Sonoma Pharmaceuticals’s (SNOA) stock price is $2.4 and Sonoma Pharmaceuticals’s (SNOA) 50-day simple moving average is 2.65, creating a Sell signal.
Sonoma Pharmaceuticals’s (SNOA) stock price is $2.4 and Sonoma Pharmaceuticals’s (SNOA) 100-day simple moving average is 2.75, creating a Sell signal.
Sonoma Pharmaceuticals’s (SNOA) stock price is $2.4 and Sonoma Pharmaceuticals’s (SNOA) 200-day simple moving average is 3.70, creating a Sell signal.

Sonoma Pharmaceuticals (SNOA) Technical Indicators

Feb 22, 2025, 11:56 PM
Name
Value
Implied Action
RSI (14)
36.31
Neutral
STOCH (9,6)
26.51
Neutral
STOCHRSI (14)
19.02
Buy
MACD (12,26)
-0.06
Buy
ADX (14)
17.19
Buy
Williams %R
-77.27
Buy
CCI (14)
-156.43
Buy
ATR (14)
0.14
-
Ultimate Oscillator
51.71
Neutral
ROC
-10.78
Sell
Sonoma Pharmaceuticals’s (SNOA) Relative Strength Index (RSI) is 36.31, creating a Neutral signal.
Sonoma Pharmaceuticals’s (SNOA) Trend Strength Indicator (ADX) is 17.19, creating a Buy signal.
Sonoma Pharmaceuticals’s (SNOA) Commodity Channel Index (CCI) is -156.43, creating a Buy signal.
Sonoma Pharmaceuticals’s (SNOA) Price Rate of Change (ROC) is -10.78, creating a Sell signal.

FAQ

Is SNOA a Buy, Hold, or Sell?
Based on SNOA’s technical indicators, SNOA is a Sell.
    What is SNOA’s RSI (14)?
    SNOA’s RSI (14) is 36.31, which suggests SNOA is a Neutral.
      What is SNOA’s MACD?
      SNOA’s MACD is -0.06, which suggests SNOA is a Buy.
        What is SNOA’s 5-day moving average?
        SNOA’s 5-day moving average is 2.46, which suggests SNOA is a Sell.
          What is SNOA’s 20-day moving average?
          SNOA 20-day moving average is 2.61, which suggests SNOA is a Sell.
            What is SNOA’s 50-day moving average?
            SNOA’s 50-day moving average is 2.65, which suggests SNOA is a Sell.
              What is SNOA’s 200-day moving average?
              SNOA’s 200-day moving average is 3.70, which suggests SNOA is a Sell.
                What is SNOA’s Williams % R (14)?
                SNOA’s Williams % R (14) is -77.27, which suggests SNOA is a Buy.
                  What is SNOA’s CCI (14)?
                  SNOA’s CCI (14) is -156.43, which suggests SNOA is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis